四位一体防治模式，济南市三院打造过敏疾病诊疗新高地

Core Insights - The Jinan Third People's Hospital Allergy Reaction Clinic has successfully implemented a "four-in-one" prevention and treatment model, utilizing multiple internationally leading anti-allergy therapies to improve the quality of life for patients with allergic diseases, marking a new phase in precise and standardized treatment in the eastern region of Jinan [1][2] Group 1: Treatment Innovations - The clinic has introduced targeted therapies such as Dupilumab for treating severe atopic dermatitis, achieving significant symptom relief and improved sleep quality for patients [1][6] - The use of Omalizumab, an anti-IgE monoclonal antibody, has shown to reduce acute attack frequency by 70% in over 80% of moderate to severe allergic asthma patients, with an average improvement of 25% in lung function (FEV1) [5] - The clinic employs subcutaneous desensitization therapy targeting house dust mite allergens, which has been effective in treating pediatric patients without significant adverse reactions [4] Group 2: Comprehensive Management Approach - The "four-in-one" prevention and treatment model includes precise allergen detection, environmental management, immune modulation, and standardized desensitization, leading to over 85% of patients experiencing significant symptom relief within three months and a reduction in recurrence rates by over 60% [2][3] - The clinic is equipped with advanced allergen detection platforms and pulmonary function rooms, ensuring comprehensive tracking from initial consultation to long-term follow-up [7] - The goal is to provide tailored treatment plans for each allergic patient, aiming not only to control symptoms but also to halt disease progression [7]